C

Cara Therapeutics

D
CARA
USD
0.0317
(9.8356%)
Market Closed
3,617.00
Volume
-1.21
EPS
-
Div Yield
-0.173529
P/E
19,415,710.21
Market Cap
Today
9.8356%
1 Week
14.120%
1 Month
31.208%
6 Months
-55.816%
12 Months
-71.452%
Year To Date
-52.547%
All Time
-95.760%

Title:
Cara Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
Do you need help or have a question?